News from NORD

Neuroendocrine Tumor Research Foundation Announces Change of Leadership

Publish date: November 2, 2017

 

After six successful years, Ron Hollander will be stepping down as executive director of the Neuroendocrine Tumor Research Foundation. His successor will be Elyse Gellerman. More.

Recommended Reading

Nominate a Colleague or Patient for a NORD Rare Impact Award
Clinician Reviews
Orphan Drugs Are Not Driving Up the Cost of Health Care, According to New Study
Clinician Reviews
NORD Call for Abstracts Reopened
Clinician Reviews
NORD Board Chair to Moderate Social Security Administration Forum
Clinician Reviews
NORD Supports Orphan Drug Tax Credit
Clinician Reviews
Small Kansas Town Turns Night Into Day for Boy With Rare Disease
Clinician Reviews
Adrenal Insufficiency United (AIU) Conference
Clinician Reviews
American Partnership for Eosinophilic Disorders (APFED) Pilot Grants
Clinician Reviews
Bridge the Gap – SYNGAP Education and Research Foundation
Clinician Reviews
Morgan Leary Vaughan Fund Receives Petit Family Foundation Grant
Clinician Reviews